{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:04:09Z","timestamp":1789657449498,"version":"4.0.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The aim of the study is to evaluate the impact of myocardial <jats:sup>123<\/jats:sup>I-metaiodobenzylguanidine (MIBG) in the diagnosis, clinical management, and differential diagnosis of Parkinson disease (PD) and non-PD parkinsonism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study enrolled 41 patients with parkinsonism. An initial diagnosis was reached after thorough clinical and imaging evaluation. After 2 to 5 years of follow-up, a final diagnosis was established. All patients underwent, soon after their initial visit, presynaptic striatal DaT scintigraphy with <jats:sup>123<\/jats:sup>I-FP-CIT (DaTscan) and <jats:sup>123<\/jats:sup>I-MIBG myocardial scintigraphy. DaTscan is not specific to distinguish among different types of neurodegenerative parkinsonism. <jats:sup>123<\/jats:sup>I-MIBG myocardial scintigraphy displays the functional status of cardiac sympathetic nerves, which is reduced in PD\/dementia with Lewy bodies (DLB) and normal in atypical parkinsonian syndromes and secondary or nondegenerative parkinsonism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>No patients showed adverse effects during or after both scintigraphies. A positive DaTscan was found in all patients in the PD\/DLB group (17\/17) and in 15 of 24 patients in the non-PD group. Myocardial <jats:sup>123<\/jats:sup>I-MIBG scintigraphy was associated with lower sensitivity (82% vs 100%) but higher specificity than DaTscan (79% vs 38%) in diagnosis PD\/DLB from non-PD parkinsonism. A positive scan result on both techniques, to confirm diagnosis of PD\/DLB, significantly improved the specificity of DaTscan, from 38% to 75%, with no reduction in sensitivity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Myocardial <jats:sup>123<\/jats:sup>I-MIBG imaging provides complementary value to <jats:sup>123<\/jats:sup>I-FP-CIT in the proper diagnosis, treatment plan, and differential diagnosis between PD and other forms of parkinsonism.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003098","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T02:30:35Z","timestamp":1589423435000},"page":"588-593","source":"Crossref","is-referenced-by-count":7,"title":["Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?"],"prefix":"10.1097","volume":"45","author":[{"given":"Maria","family":"Stathaki","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Koukouraki","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Simos","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Crete, Institute of Computer Science, Foundation for Research and Technology-Hellas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iro","family":"Boura","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital, Heraklion, Crete, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouela","family":"Papadaki","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Bourogianni","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Tsaroucha","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kapsoritakis","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Mitsias","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital, Heraklion, Crete, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleanthe","family":"Spanaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital, Heraklion, Crete, Greece."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"bib1-20230928","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/ene.12444","article-title":"[123I]FP-CIT SPECT (DaTscan) may be a useful tool to differentiate between Parkinson\u2019s disease and vascular or drug-induced parkinsonisms: a meta-analysis","volume":"21","year":"2014","journal-title":"Eur J Neurol"},{"key":"bib2-20230928","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2014.10.022","article-title":"Experience with DaTscan at a tertiary referral center","volume":"21","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"bib3-20230928","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson\u2019s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"bib4-20230928","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.108.059998","article-title":"Imaging approaches to Parkinson disease","volume":"51","year":"2010","journal-title":"J Nucl Med"},{"key":"bib5-20230928","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinson\u2019s disease","volume":"5","year":"2006","journal-title":"Lancet Neurol"},{"key":"bib6-20230928","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-006-0518-2","article-title":"Striatal FP-CIT uptake differs in the subtypes of early Parkinson\u2019s disease","volume":"114","year":"2007","journal-title":"J Neural Transm (Vienna)"},{"key":"bib7-20230928","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.parkreldis.2014.04.019","article-title":"Diagnostic accuracy of parkinsonism syndromes by general neurologists","volume":"20","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"bib8-20230928","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2967\/jnumed.110.086959","article-title":"Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib9-20230928","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.parkreldis.2014.05.011","article-title":"Differentiating drug-induced parkinsonism from Parkinson\u2019s disease: an update on non-motor symptoms and investigations","volume":"20","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"bib10-20230928","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","article-title":"MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis","volume":"22","year":"2012","journal-title":"Clin Auton Res"},{"key":"bib11-20230928","article-title":"Diagnostic and pathophysiological impact of myocardial MIBG scintigraphy in Parkinson\u2019s disease","volume":"2010","year":"2010","journal-title":"Parkinsons Dis"},{"key":"bib12-20230928","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.clineuro.2011.09.004","article-title":"Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson\u2019s disease and multiple-system atrophy: a systematic review and a meta-analysis","volume":"113","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"bib13-20230928","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/mds.23338","article-title":"Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy","volume":"25","year":"2010","journal-title":"Mov Disord"},{"key":"bib14-20230928","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/mds.20594","article-title":"Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2","volume":"20","year":"2005","journal-title":"Mov Disord"},{"key":"bib15-20230928","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","year":"1967","journal-title":"Neurology"},{"key":"bib16-20230928","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12149-012-0577-4","article-title":"SPECT study with I-123-ioflupane (DaTscan) in patients with essential tremor. Is there any correlation with Parkinson\u2019s disease?","volume":"26","year":"2012","journal-title":"Ann Nucl Med"},{"key":"bib17-20230928","first-page":"371","article-title":"Imaging in Parkinson\u2019s disease","volume":"16","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"bib18-20230928","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/jnnp-2012-304436","article-title":"Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes","volume":"84","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib19-20230928","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5603\/NMR.2013.0007","article-title":"Neurological applications for myocardial MIBG scintigraphy","volume":"16","year":"2013","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"bib20-20230928","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s12149-013-0702-z","article-title":"Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson\u2019s disease","volume":"27","year":"2013","journal-title":"Ann Nucl Med"},{"key":"bib21-20230928","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00259-011-1754-8","article-title":"Diagnostic cutoff points for 123I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson\u2019s disease","volume":"38","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib22-20230928","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?","volume":"24","year":"2014","journal-title":"J Neuroimaging"},{"key":"bib23-20230928","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MNM.0000000000000674","article-title":"The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes","volume":"38","year":"2017","journal-title":"Nucl Med Commun"},{"key":"bib24-20230928","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s12149-014-0878-x","article-title":"Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with PD and APS using DaTscan SPECT","volume":"28","year":"2014","journal-title":"Ann Nucl Med"},{"key":"bib25-20230928","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00259-004-1578-x","article-title":"Imaging of dopamine transporters and D2 receptors in patients with PD and MSA","volume":"31","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib26-20230928","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.1265","article-title":"Progression of dopamine degeneration in PD and atypical parkinsonism: a longitudinal \u03b2-CIT SPECT study","volume":"17","year":"2002","journal-title":"Mov Disord"},{"key":"bib27-20230928","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","article-title":"[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration","volume":"15","year":"2000","journal-title":"Mov Disord"},{"key":"bib28-20230928","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jns.2015.10.059","article-title":"Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake","volume":"359","year":"2015","journal-title":"J Neurol Sci"},{"key":"bib29-20230928","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/ene.13206","article-title":"Normal \u2018heart\u2019 in Parkinson\u2019s disease: is this a distinct clinical phenotype?","volume":"24","year":"2017","journal-title":"Eur J Neurol"},{"key":"bib30-20230928","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MNM.0b013e3282f4d307","article-title":"Striatal dopamine transporter abnormalities in patients with essential tremor","volume":"29","year":"2008","journal-title":"Nucl Med Commun"},{"key":"bib31-20230928","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.parkreldis.2006.05.033","article-title":"Exploring the relationship between essential tremor and Parkinson\u2019s disease","volume":"13","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"bib32-20230928","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/mds.22655","article-title":"Essential tremor in Parkinson\u2019s disease kindreds from population of similar genetic background","volume":"24","year":"2009","journal-title":"Mov Disord"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:36:53Z","timestamp":1695872213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003098","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,12]]}}}